Inflammation-tumor burden interaction score stratifies survival after irinotecan-eluting bead chemoembolization for colorectal liver metastases

Tolga Doğan, Semra Taş, Emre Hafızoğlu, Taliha Güçlü Kantar, Burçin Çakan Demirel, Emre İspir, Erdem Çomut, Muhammet Arslan, Burcu Yapar Taşköylü, Atike Gökçen Demiray, Arzu Yaren, Gamze Gököz Doğu

Open source

DOI
10.3389/fmed.2026.1751660
Published
2026-03-12
Container
Frontiers in Medicine
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2026.1751660,
  title = {Inflammation-tumor burden interaction score stratifies survival after irinotecan-eluting bead chemoembolization for colorectal liver metastases},
  author = {Tolga Doğan and Semra Taş and Emre Hafızoğlu and Taliha Güçlü Kantar and Burçin Çakan Demirel and Emre İspir and Erdem Çomut and Muhammet Arslan and Burcu Yapar Taşköylü and Atike Gökçen Demiray and Arzu Yaren and Gamze Gököz Doğu},
  year = {2026},
  journal = {Frontiers in Medicine},
  doi = {10.3389/fmed.2026.1751660},
  url = {https://doi.org/10.3389/fmed.2026.1751660}
}

RIS

TY  - JOUR
TI  - Inflammation-tumor burden interaction score stratifies survival after irinotecan-eluting bead chemoembolization for colorectal liver metastases
AU  - Tolga Doğan
AU  - Semra Taş
AU  - Emre Hafızoğlu
AU  - Taliha Güçlü Kantar
AU  - Burçin Çakan Demirel
AU  - Emre İspir
AU  - Erdem Çomut
AU  - Muhammet Arslan
AU  - Burcu Yapar Taşköylü
AU  - Atike Gökçen Demiray
AU  - Arzu Yaren
AU  - Gamze Gököz Doğu
PY  - 2026
JO  - Frontiers in Medicine
DO  - 10.3389/fmed.2026.1751660
UR  - https://doi.org/10.3389/fmed.2026.1751660
ER  - 

APA

Doğan, T., Taş, S., Hafızoğlu, E., Kantar, T. G., Demirel, B. Ç., İspir, E., Çomut, E., Arslan, M., Taşköylü, B. Y., Demiray, A. G., Yaren, A., & Doğu, G. G. (2026). Inflammation-tumor burden interaction score stratifies survival after irinotecan-eluting bead chemoembolization for colorectal liver metastases. Frontiers in Medicine. https://doi.org/10.3389/fmed.2026.1751660

Source records